Development of second primary small-cell lung cancer within the irradiated field after chemoradiotherapy: a report of two cases

Respirol Case Rep. 2021 May 25;9(6):e00767. doi: 10.1002/rcr2.767. eCollection 2021 Jun.

Abstract

Two male smokers developed small-cell lung cancer (SCLC) as the second primary malignancy (SPM) in the irradiated field after concurrent chemoradiotherapy for locally advanced cancer, which could also be considered as a radiation-induced tumour. A 70-year-old man received cisplatin and S-1 and irradiation at 60 Gy for lung adenocarcinoma eight years previously and an 81-year-old man cisplatin and 5-fluorouracil and at irradiation 60 Gy for oesophageal cancer five years previously. They sequentially received chemotherapy for SCLC, the effects of which were limited, and a refractory course was noted. Chemoradiotherapy is an effective treatment strategy for locally advanced cancer but may be relevant to the onset of SCLC as SPM.

Keywords: Chemotherapy; lung cancer; oesophageal cancer; radiation‐induced tumour; small‐cell lung carcinoma.

Publication types

  • Case Reports